Literature DB >> 18165914

Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.

Taoufik Khalfaoui1, Gérard Lizard, Amel Ouertani-Meddeb.   

Abstract

The expression of intercellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) were studied in the conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination including ocular fundus and retinal fluorescein angiography. The indirect immunoperoxidase method was performed on 15 normal conjunctivas taken during cataract surgery (group 1), on 40 eyes of 40 patients with type 2 diabetes without diabetic retinopathy (DR) (group 2) and 13 eyes of 13 patients with DR (group 3). ICAM-1 and VCAM-1 are located in epithelial cells, vascular endothelial cells and in stromal cells. Our results show a statistically significant increase in the immunohistochemical expression of these proteins in the conjunctiva of diabetic patients with and without DR in comparison with normal conjunctiva (P = 0.001). Noteworthy, ICAM-1 and VCAM-1 are upregulated in the conjunctiva of diabetic patients with and without retinopathy, reflecting the inflammatory nature of this condition and suggesting a possible role for these mediators in the pathogenesis of diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165914     DOI: 10.1007/s10735-007-9159-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  32 in total

1.  Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations.

Authors:  D B Archer
Journal:  Eye (Lond)       Date:  1999-08       Impact factor: 3.775

2.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.

Authors:  Alvin K H Cheung; Maggie K L Fung; Amy C Y Lo; Terence T L Lam; Kwok Fai So; Stephen S M Chung; Sookja K Chung
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

4.  Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells.

Authors:  K E Platts; M T Benson; I G Rennie; R M Sharrard; R C Rees
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-10       Impact factor: 4.799

5.  Expression of apoptosis markers in the retinas of human subjects with diabetes.

Authors:  Ahmed M Abu-El-Asrar; Lieve Dralands; Luc Missotten; Ibrahim A Al-Jadaan; Karel Geboes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

6.  Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells.

Authors:  Weiqin Chen; Donald B Jump; Maria B Grant; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

7.  Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients.

Authors:  Lidia Kria; Taoufik Khalfaoui; Ghada Mkannez; Omar Beltaief; Raja Anane; Khalil Errais; Lilia Tounsi; Raja Zhioua; Sarra Ben Jilani; Amel Meddeb Ouertani
Journal:  J Mol Histol       Date:  2006-02-16       Impact factor: 2.611

8.  Role of interleukin-1beta in the pathogenesis of diabetic retinopathy.

Authors:  R A Kowluru; S Odenbach
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

9.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

10.  Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation.

Authors:  T S Altannavch; K Roubalová; P Kucera; M Andel
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

View more
  25 in total

1.  Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line.

Authors:  A B El-Remessy; M Rajesh; P Mukhopadhyay; B Horváth; V Patel; M M H Al-Gayyar; B A Pillai; P Pacher
Journal:  Diabetologia       Date:  2011-03-04       Impact factor: 10.122

2.  Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.

Authors:  Nazmun Nahar; Suhaila Mohamed; Noordin Mohamed Mustapha; SengFong Lau; Nur Iliyani Mohd Ishak; Norshahira Solehah Umran
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-13       Impact factor: 3.000

3.  Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy.

Authors:  Yufei Wang; Hongdan Yu; Jing Li; Wenqiang Liu; Shengxue Yu; Pan Lv; Lipan Zhao; Xiaobai Wang; Zhongfu Zuo; Xuezheng Liu
Journal:  Cell Tissue Res       Date:  2022-10-06       Impact factor: 4.051

4.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

Authors:  Rajeev H Muni; Radha P Kohly; Eudocia Q Lee; JoAnn E Manson; Richard D Semba; Debra A Schaumberg
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

6.  The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Authors:  Megan E Capozzi; Sara R Savage; Gary W McCollum; Sandra S Hammer; Carla J Ramos; Rong Yang; Colin A Bretz; John S Penn
Journal:  Exp Eye Res       Date:  2019-11-20       Impact factor: 3.467

7.  The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.

Authors:  Barbora Hermankova; Jan Kossl; Pavla Bohacova; Eliska Javorkova; Michaela Hajkova; Magdalena Krulova; Alena Zajicova; Vladimir Holan
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

8.  12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase.

Authors:  Amira Othman; Saif Ahmad; Sylvia Megyerdi; Rene Mussell; Karishma Choksi; Krishna Rao Maddipati; Ahmed Elmarakby; Nasser Rizk; Mohamed Al-Shabrawey
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia.

Authors:  Carin Gustavsson; Carl-David Agardh; Anna V Zetterqvist; Jan Nilsson; Elisabet Agardh; Maria F Gomez
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

Review 10.  Neuroinflammatory responses in diabetic retinopathy.

Authors:  Ying Yu; Hui Chen; Shao Bo Su
Journal:  J Neuroinflammation       Date:  2015-08-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.